SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 33 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $693,000 | -0.3% | 517,078 | +9.4% | 0.00% | 0.0% |
| Q2 2020 | $695,000 | +122.0% | 472,530 | +40.2% | 0.00% | – |
| Q1 2020 | $313,000 | -1.3% | 336,927 | +67.7% | 0.00% | – |
| Q4 2019 | $317,000 | -38.4% | 200,930 | +34.1% | 0.00% | – |
| Q3 2019 | $515,000 | +6.4% | 149,800 | +14.2% | 0.00% | – |
| Q2 2019 | $484,000 | +25.1% | 131,200 | +255.6% | 0.00% | – |
| Q1 2019 | $387,000 | +22.1% | 36,900 | +21.0% | 0.00% | – |
| Q4 2018 | $317,000 | -8.6% | 30,500 | +5.9% | 0.00% | – |
| Q3 2018 | $347,000 | +88.6% | 28,800 | +85.8% | 0.00% | – |
| Q2 2018 | $184,000 | -67.8% | 15,500 | -54.3% | 0.00% | -100.0% |
| Q3 2017 | $571,000 | +23.6% | 33,883 | -0.6% | 0.00% | 0.0% |
| Q2 2017 | $462,000 | – | 34,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 615,384 | $8,332,000 | 1.29% |
| RTW INVESTMENTS, LP | 250,000 | $3,385,000 | 0.71% |
| Monashee Investment Management LLC | 100,000 | $1,354,000 | 0.57% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 275,728 | $3,733,000 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 175,000 | $2,370,000 | 0.40% |
| TIEDEMANN ADVISORS, LLC | 362,049 | $4,902,000 | 0.36% |
| Morse Asset Management, Inc | 63,700 | $862,000 | 0.28% |
| Private Capital Advisors, Inc. | 56,250 | $762,000 | 0.25% |
| Crestline Management, LP | 98,581 | $1,335,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 112,500 | $1,523,000 | 0.17% |